1150_Garcia.pdf

1、The long SFA lesionOptions whats best?Lawrence A.Garcia,MDDirector,Vascular ServicesCatholic Health Services,Long IslandSt.Francis Hospital and Heart CenterRoslyn,NYDisclosure Statement of Financial InterestGrant/Research SupportConsulting(non-compensated)Major Stock Shareholder/EquityRoyalty Income

2、Ownership/FounderIntellectual Property RightsOther Financial BenefitAbbott,Medtronic,BSCMedtronic,Boston Scientific,Abbott,PhillipsPrimacea,TissueGen,Orchestra,R3 Vascular,Transit Medical,Syntervention,CagentNone Innovation Vascular PartnersNone None Within the past 12 months,I or my spouse/partner

3、have had a financial interest/arrangement or affiliation with the organization(s)listed below.Affiliation/Financial RelationshipCompany 104 patients Claudicants/CLI StentPTARB4 12%13%ABI StentPTA 0.570.54Schillinger NEJM 200610.19.237324315051015202530354045Lesion length(cm)Occlusion(%)Stent2(%)Sten

4、tPTA At two years Stenting 46%PTA 69%p0.04 Clinical difference 43%vs 33%P=NS Walking distance No differenceTLRTVRSchillinger Circ 2007115:2745-2749ABSOLUTE 2-yearZILVER PTX5-Year Primary Patency(PSVR 2.0)Zilver PTX vs.Standard Care5-Year Freedom from TLRZilver PTX vs.Standard Care Munster registry E

5、luvia DES LL 19 cm PP 5 years 65%CD-TLR 5 years 79%Torsello G CVIR 20SUPERB37.5%57.2%5.3%234Rutherford-Becker CategoryPatient CharacteristicsITT(N=264)Age(mean)68.7Male63.6%History of coronary disease66.9%History of MI20.3%Diabetes43.5%Current smoker31.8%Renal insufficiency9.1%Any previous periphera

6、l artery surgical revascularization38.0%Garcia LA et al Catheter Cardiolvasc Interv 2017Freedom from Loss of Primary Patency at 1 Year (PSVR 40%)VIASTAR:Lesion Characteristics Lammer,et al.JACC.2013.VIABAHNn=72BMSn=69p-value%Chronic Occlusions79%70%0.21Lesion Length(mm)1901730.13TASC Classification0